Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Circulating interferon-α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity.

Melki I, Devilliers H, Gitiaux C, Bondet V, Belot A, Bodemer C, Quartier P, Crow YJ, Duffy D, Rodero MP, Bader Meunier B.

Arthritis Rheumatol. 2019 Sep 5. doi: 10.1002/art.41096. [Epub ahead of print]

PMID:
31487101
2.

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.

Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Bader-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonné Y, Kirchhoff F, Sanchez Garcia E, Charbit B, Leboulanger N, Jahrsdörfer B, Richard Y, Korganow AS, Münch J, Nisole S, Duffy D, Herbeuval JP.

Sci Adv. 2019 Jul 10;5(7):eaav9019. doi: 10.1126/sciadv.aav9019. eCollection 2019 Jul.

3.

Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS.

Gratia M, Rodero MP, Conrad C, Bou Samra E, Maurin M, Rice GI, Duffy D, Revy P, Petit F, Dale RC, Crow YJ, Amor-Gueret M, Manel N.

J Exp Med. 2019 May 6;216(5):1199-1213. doi: 10.1084/jem.20181329. Epub 2019 Apr 1.

PMID:
30936263
4.

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Rice GI, Meyzer C, Bouazza N, Hully M, Boddaert N, Semeraro M, Zeef LAH, Rozenberg F, Bondet V, Duffy D, Llibre A, Baek J, Sambe MN, Henry E, Jolaine V, Barnerias C, Barth M, Belot A, Cances C, Debray FG, Doummar D, Frémond ML, Kitabayashi N, Lepelley A, Levrat V, Melki I, Meyer P, Nougues MC, Renaldo F, Rodero MP, Rodriguez D, Roubertie A, Seabra L, Uggenti C, Abdoul H, Treluyer JM, Desguerre I, Blanche S, Crow YJ.

N Engl J Med. 2018 Dec 6;379(23):2275-7. doi: 10.1056/NEJMc1810983. No abstract available.

5.

Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.

Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J, Kula T, Drutman S, Belkaya S, Rattina V, Lorenzo-Diaz L, Boulai A, Rose Y, Kitabayashi N, Rodero MP, Dumaine C, Blanche S, Lebras MN, Leung MC, Mathew LS, Boisson B, Zhang SY, Boisson-Dupuis S, Giliani S, Chaussabel D, Notarangelo LD, Elledge SJ, Ciancanelli MJ, Abel L, Zhang Q, Marr N, Crow YJ, Su HC, Casanova JL.

J Exp Med. 2018 Oct 1;215(10):2567-2585. doi: 10.1084/jem.20180628. Epub 2018 Aug 24.

6.

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α.

Llibre A, Bondet V, Rodero MP, Hunt D, Crow YJ, Duffy D.

J Vis Exp. 2018 Jun 14;(136). doi: 10.3791/57421.

7.

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.

Ladislau L, Suárez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, Rodero MP, Hathazi D, Duffy D, Bondet V, Preusse C, Bienvenu B, Rozenberg F, Roos A, Benjamim CF, Gallardo E, Illa I, Mouly V, Stenzel W, Butler-Browne G, Benveniste O, Allenbach Y.

Brain. 2018 Jun 1;141(6):1609-1621. doi: 10.1093/brain/awy105.

PMID:
29741608
8.

Type I interferon-mediated autoinflammation due to DNase II deficiency.

Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ.

Nat Commun. 2017 Dec 19;8(1):2176. doi: 10.1038/s41467-017-01932-3.

9.

Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization.

Lee J, Rodero MP, Patel J, Moi D, Mazzieri R, Khosrotehrani K.

FASEB J. 2018 Apr;32(4):2086-2094. doi: 10.1096/fj.201700773R. Epub 2018 Jan 5.

PMID:
29208701
10.

Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.

Gitiaux C, Latroche C, Weiss-Gayet M, Rodero MP, Duffy D, Bader-Meunier B, Glorion C, Nusbaum P, Bodemer C, Mouchiroud G, Chelly J, Germain S, Desguerre I, Chazaud B.

Arthritis Rheumatol. 2018 Jan;70(1):134-145. doi: 10.1002/art.40328. Epub 2017 Nov 28.

11.

Polymorphisms in IFIH1: the good and the bad.

Della Mina E, Rodero MP, Crow YJ.

Nat Immunol. 2017 Jun 20;18(7):708-709. doi: 10.1038/ni.3765. No abstract available.

12.

Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.

Frémond ML, Uggenti C, Van Eyck L, Melki I, Bondet V, Kitabayashi N, Hertel C, Hayday A, Neven B, Rose Y, Duffy D, Crow YJ, Rodero MP.

Arthritis Rheumatol. 2017 Jul;69(7):1495-1501. doi: 10.1002/art.40122. Epub 2017 Jun 5.

13.

Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, McGlasson SL, Alyanakian MA, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs TA, Desguerre I, Frémond ML, Hully M, van den Maagdenberg AMJM, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt GM, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert ML, Rozenberg F, Crow YJ, Duffy D.

J Exp Med. 2017 May 1;214(5):1547-1555. doi: 10.1084/jem.20161451. Epub 2017 Apr 18.

14.

Corrigendum: Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317b. No abstract available.

PMID:
28138155
15.

Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.

Melki I, Rose Y, Uggenti C, Van Eyck L, Frémond ML, Kitabayashi N, Rice GI, Jenkinson EM, Boulai A, Jeremiah N, Gattorno M, Volpi S, Sacco O, Terheggen-Lagro SWJ, Tiddens HAWM, Meyts I, Morren MA, De Haes P, Wouters C, Legius E, Corveleyn A, Rieux-Laucat F, Bodemer C, Callebaut I, Rodero MP, Crow YJ.

J Allergy Clin Immunol. 2017 Aug;140(2):543-552.e5. doi: 10.1016/j.jaci.2016.10.031. Epub 2017 Jan 10. Erratum in: J Allergy Clin Immunol. 2017 Dec;140(6):1757.

PMID:
28087229
16.

Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease.

Rice GI, Melki I, Frémond ML, Briggs TA, Rodero MP, Kitabayashi N, Oojageer A, Bader-Meunier B, Belot A, Bodemer C, Quartier P, Crow YJ.

J Clin Immunol. 2017 Feb;37(2):123-132. doi: 10.1007/s10875-016-0359-1. Epub 2016 Dec 9.

17.

Functional Definition of Progenitors Versus Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process.

Patel J, Seppanen EJ, Rodero MP, Wong HY, Donovan P, Neufeld Z, Fisk NM, Francois M, Khosrotehrani K.

Circulation. 2017 Feb 21;135(8):786-805. doi: 10.1161/CIRCULATIONAHA.116.024754. Epub 2016 Nov 29.

PMID:
27899395
18.

Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Rodero MP, Crow YJ.

J Exp Med. 2016 Nov 14;213(12):2527-2538. Epub 2016 Nov 7. Review.

19.

JAK inhibition in STING-associated interferonopathy.

Rodero MP, Frémond ML, Rice GI, Neven B, Crow YJ.

Ann Rheum Dis. 2016 Dec;75(12):e75. doi: 10.1136/annrheumdis-2016-210504. Epub 2016 Oct 12. No abstract available.

PMID:
27733349
20.

Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2016 Oct;48(10):1185-92. doi: 10.1038/ng.3661. Epub 2016 Aug 29. Erratum in: Nat Genet. 2017 Jan 31;49(2):317.

21.

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

Frémond ML, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, Bessis D, Cros G, Rice GI, Charbit B, Hulin A, Khoudour N, Caballero CM, Bodemer C, Fabre M, Berteloot L, Le Bourgeois M, Reix P, Walzer T, Moshous D, Blanche S, Fischer A, Bader-Meunier B, Rieux-Laucat F, Crow YJ, Neven B.

J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755. doi: 10.1016/j.jaci.2016.07.015. Epub 2016 Aug 20. No abstract available.

22.

ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters.

Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, Deiva K, Touitou I, Crow YJ, Quartier P.

RMD Open. 2016 May 16;2(1):e000236. doi: 10.1136/rmdopen-2015-000236. eCollection 2016.

23.

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

Rowe CJ, Tang F, Hughes MC, Rodero MP, Malt M, Lambie D, Barbour A, Hayward NK, Smithers BM, Green AC, Khosrotehrani K.

Int J Cancer. 2016 Aug 1;139(3):664-72. doi: 10.1002/ijc.30085. Epub 2016 Apr 4.

24.

cGMP-AMP synthase paves the way to autoimmunity.

Rodero MP, Crow YJ.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):12903-4. doi: 10.1073/pnas.1517578112. Epub 2015 Oct 8. No abstract available.

25.

ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis.

Lee JS, Seppanen E, Patel J, Rodero MP, Khosrotehrani K.

Exp Dermatol. 2016 Jan;25(1):71-4. doi: 10.1111/exd.12833. Epub 2015 Oct 6. No abstract available.

PMID:
26314835
26.

Immune surveillance of the lung by migrating tissue monocytes.

Rodero MP, Poupel L, Loyher PL, Hamon P, Licata F, Pessel C, Hume DA, Combadière C, Boissonnas A.

Elife. 2015 Jul 13;4:e07847. doi: 10.7554/eLife.07847.

27.

Lack of Evidence From a Transgenic Mouse Model that the Activation and Migration of Melanocytes to the Epidermis after Neonatal UVR Enhances Melanoma Development.

Handoko HY, Rodero MP, Muller HK, Khosrotehrani K, Walker GJ.

J Invest Dermatol. 2015 Nov;135(11):2897-2900. doi: 10.1038/jid.2015.203. Epub 2015 Jun 2. No abstract available.

28.

Tracking mouse bone marrow monocytes in vivo.

Hamon P, Rodero MP, Combadière C, Boissonnas A.

J Vis Exp. 2015 Feb 27;(96):e52476. doi: 10.3791/52476.

29.

Human disease phenotypes associated with mutations in TREX1.

Rice GI, Rodero MP, Crow YJ.

J Clin Immunol. 2015 Apr;35(3):235-43. doi: 10.1007/s10875-015-0147-3. Epub 2015 Mar 4. Review.

PMID:
25731743
30.

In vivo imaging reveals a pioneer wave of monocyte recruitment into mouse skin wounds.

Rodero MP, Licata F, Poupel L, Hamon P, Khosrotehrani K, Combadiere C, Boissonnas A.

PLoS One. 2014 Oct 1;9(10):e108212. doi: 10.1371/journal.pone.0108212. eCollection 2014. Erratum in: PLoS One. 2014;9(12):e115508.

31.

Differential effects of ultraviolet irradiation in neonatal versus adult mice are not explained by defective macrophage or neutrophil infiltration.

Rodero MP, Handoko HY, Villani RM, Walker GJ, Khosrotehrani K.

J Invest Dermatol. 2014 Jul;134(7):1991-1997. doi: 10.1038/jid.2014.78. Epub 2014 Feb 7.

32.

Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice.

Rodero MP, Auvynet C, Poupel L, Combadière B, Combadière C.

Neoplasia. 2013 Jun;15(6):641-8.

33.

UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages.

Handoko HY, Rodero MP, Boyle GM, Ferguson B, Engwerda C, Hill G, Muller HK, Khosrotehrani K, Walker GJ.

J Invest Dermatol. 2013 Jul;133(7):1803-12. doi: 10.1038/jid.2013.9. Epub 2013 Jan 15.

34.

Wound-associated macrophages control collagen 1α2 transcription during the early stages of skin wound healing.

Rodero MP, Legrand JM, Bou-Gharios G, Khosrotehrani K.

Exp Dermatol. 2013 Feb;22(2):143-5. doi: 10.1111/exd.12068. Epub 2013 Jan 2.

PMID:
23278967
35.

Reduced Il17a expression distinguishes a Ly6c(lo)MHCII(hi) macrophage population promoting wound healing.

Rodero MP, Hodgson SS, Hollier B, Combadiere C, Khosrotehrani K.

J Invest Dermatol. 2013 Mar;133(3):783-792. doi: 10.1038/jid.2012.368. Epub 2012 Dec 13.

36.

Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathway.

Rodero MP, Prignon A, Avril MF, Boitier F, Aractingi S, Khosrotehrani K.

J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e144-5. doi: 10.1111/j.1468-3083.2012.04550.x. Epub 2012 May 2. No abstract available.

PMID:
22548459
37.

Skin wound healing modulation by macrophages.

Rodero MP, Khosrotehrani K.

Int J Clin Exp Pathol. 2010 Jul 25;3(7):643-53. Review.

38.

Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.

Cochain C, Rodero MP, Vilar J, Récalde A, Richart AL, Loinard C, Zouggari Y, Guérin C, Duriez M, Combadière B, Poupel L, Lévy BI, Mallat Z, Combadière C, Silvestre JS.

Cardiovasc Res. 2010 Oct 1;88(1):186-95. doi: 10.1093/cvr/cvq153. Epub 2010 May 25.

PMID:
20501509

Supplemental Content

Loading ...
Support Center